Amivantamab efficacy in wild-type EGFR NSCLC tumors correlates with levels of ligand expression.
Rivera-Soto R, Henley B, Pulgar MA, Lehman SL, Gupta H, Perez-Vale KZ, Weindorfer M, Vijayaraghavan S, Yao TS, Laquerre S, Moores SL.
Rivera-Soto R, et al. Among authors: vijayaraghavan s.
NPJ Precis Oncol. 2024 Sep 6;8(1):192. doi: 10.1038/s41698-024-00682-y.
NPJ Precis Oncol. 2024.
PMID: 39242834
Free PMC article.